Personalis (PSNL) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

PSNL Personalis

Watchlist

5.730
-0.220-3.70%

Close Sep 12 16:00 ET

6.010
+0.280+4.89%

Pre 08:09 ET

377.81MMarket Cap-3493P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Personalis Inc Files for Resale of up to 3.5 Mln Shares by the Selling Stockholders - SEC Filing
ReutersAug 30 16:44 ET
Further Upside For Personalis, Inc. (NASDAQ:PSNL) Shares Could Introduce Price Risks After 73% Bounce
Simply Wall StAug 26 06:19 ET
Personalis to Participate at Upcoming Investor Conferences
BusinesswireAug 22 16:01 ET
BTIG Maintains Personalis(PSNL.US) With Buy Rating, Maintains Target Price $7
Moomoo NewsAug 21 06:31 ET · Ratings
Personalis (PSNL) Receives a Buy From BTIG
TipRanksAug 21 06:27 ET · Ratings
Express News | Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersAug 19 16:05 ET

Comments

Stock_Drift

Aug 18 17:37

8/19/24 🦍’s 👀’s on 🚨🚨🚨🚨

$Virax Biolabs (VRAX.US)$ $Airship AI (AISP.US)$ $Personalis (PSNL.US)$ $Emergent BioSolutions (EBS.US)$ $Chimerix (CMRX.US)$ $Tonix Pharmaceuticals (TNXP.US)$
📊⚡️📊

Stock Region

Aug 18 17:13

Medical Company Announces Expanded Collaboration With Technology Firm

Expanding Horizons in Cancer Management: The Collaboration of Personalis, Inc. and Tempus AI, Inc..
In a world where technological advancements continually reshape the landscape of healthcare, collaboration among industry leaders plays a pivotal role in accelerating innovation. A testament to this is the expanded collaboration between Personalis, Inc., a renowned leader in cancer genomics, and Tempus AI, Inc., a technology-driv...